In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 95464-05-4, name is 1,1′-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex, introducing its new discovery. Formula: C35H32Cl4FeP2Pd
This paper presents an experimental and theoretical investigation of the Pd-catalyzed Negishi coupling reaction and reveals a novel second transmetalation reaction between an Ar1-Pd-Ar2 species and the organozinc reagent Ar2-ZnX. Understanding of this second step reveals how homocoupling and dehalogenation products are formed. Thus, the second transmetalation generates Ar2PdAr2 and Ar 1ZnCl, which upon reductive elimination and hydrolysis, respectively, give the homocoupling product Ar2-Ar2 and the dehalogenation product Ar1H. The ratio of the cross-coupling product Ar1-Ar2 and the homocoupling product Ar 2-Ar2 is determined by competition between the second transmetalation and reductive elimination steps. This mechanism is further supported by density functional theoretical calculations. Calculations on a series of reactions suggest a strategy in controlling the selectivity of cross-coupling and homocoupling pathways, which we have experimentally verified.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 95464-05-4, and how the biochemistry of the body works.Formula: C35H32Cl4FeP2Pd
Reference：
Chapter 1 An introduction to palladium catalysis,
Palladium/carbon catalyst regeneration and mechanical application method